1. Faik RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997; 337(13): 898-909
2. Hawkins PN. Diagnosis and treatment of amyloidosis. Ann Rheum Dis 1997; 56: 631-633
3.
Özdemi
r Aİ. Üç yüz böbrek amiloidozisinin değerlendirilmesi. IV. Böbrek Hastalıkları ve Transplantasyon Kongresi 1987, s 33
4.
Arı
k N, Taşdemir I, Özyılkan Ö ve ark. 222 renal amiloidozis vakasında klinik ve laboratuvar özellikler. VI. Ulusal Böbrek Hastalıkları ve Transplantasyon Kongresi 1989, s 42
5. Stone MJ. Amyloidosis: a final common pathway for protein deposition in tissues. J Am Society of Hematol 1990; 75(3): 531-545
6. Clinicopathologic conference. Nephrotic syndrome in a
76-year-old man. Am J Med 1991; 91: 80-88
7. Gillmore JD, Hawkins PN, Pepys MB. Amyloidosis: a review of recent diagnostic and therapeutic
developments. Br J Haematol 1997; 99(2): 245-256
8. Tınaztepe K. Renal amyloidosis in childhood. An overview of the topic with 25 years experience. Turk J
Pediatr 1995; 37(4): 357-373
9. Benson MD. Amyloidosis in: Arthritis and Allied Condition. A Textbook of Rheumatology. Koopman WJ
(ed). 1997 Williams&Wilkins, Baltimore, p 1661-1688
10. Laakso M, Mutru O, Isomaki H, Koota K. Mortality from amyloidosis and renal disease in patients with rheumatoid arthritis. Ann Rheum Dis 1986; 45:663-667
11.
Akoğl
u E, Başlamışlı F, Demirtaş M, Sağhker Y, Gürçay AA. Çukurova bölgesinde görülen amiloidoz olgularının klinik değerlendirilmesi. V. Böbrek Hastalıkları ve Transplantasyon Kongresi
12. Ben-Chetrit E, Levy M. Familial Mediterranean Fever. Lancet 1998;351:659-664
13. Yazıcı H, Özdoğan H. Familial Mediterranean Fever in Turkey. In: Sohar E, Gafm J, Pras M, eds. Proceedings of the 1 St International conference on FMF. Tel Aviv:
Freund, 1997:66-71.
14. Özdemir Al, Sökmen C. Familial Mediterranean Fever among the Turkish people. Am J Gastroenterol 1969;
51:311-316.
15. Miller LD, Brown EC Jr, Arnett FC. Amyloidosis in Reiter's syndrome. J Rheumatol 1979; 6: 225-231
16. Lehtinen K. Cause of death in 79 patients with ankylosing spondylitis. Scand J Rheumatol 1980; 9(3): 145-147
17. Düşen N, Konice M, Aral O et al. Behcet's disease associated with amyloidosis in Turkey and in the world.
Ann Rheum Dis 1988; 47(2): 157-163
18. Yurdakul S, Tüzüner N, Yurdakul I, Hamuryudan V, Yazıcı H. Amyloidosis in Behcet's syndrome. Arthritis
Rheum 1990; 33(10): 1586-1589
19. Petterson T, Torntroth T, Totterman KJ, Fortelius P, Maury CP. AA amyloidosis in Systemic Lupus
Erythematosus. J Rheumatol 1987; 14(4): 835-838
20. Jain S, Taraphdar A, Joski K et al. Renal amyloidosis complicating Takayasu's arteritis: A rare association.
Nephrol Dial Transplant 1992; 7(11):1133-1135
21. Ateş K, Ertürk S, Diker E et al. Renal amyloidosis complicating Takayasu's arteritis: A Case report.
Nephron 1996; 73(1): 111-112
22. Tan SY, Pepsy MB, Hawkins PN. Treatment of amyloidosis. Am J Kidney Dis 1995; 26(2): 267-285
23. Saatçi U, Özen S, Özdemir S, et al. Familial Mediterranean Fever in children: report of a large series and discussion of the risk and prognostic factors of
amyloidosis. Eur J Pediatr 1997; 156(8): 619-623
24. Livneh A, Zemer D, Langevitz P, et al. Colchicine treatment of AA amyloidosis of Familial Mediterranean Fever. An analysis of factors affecting outcome.
Arthritis Rheum 1994; 37(12): 1804-1811
25. M Yavuz. l<. Dilek, M Güllülü, M Yurtkuran:
Angiotensin konverting enzim inhibitörü enalaprilin proteinüri ve diğer böbrek fonksiyonlarına etkisi. Uludağ Üniversitesi Tıp Fakültesi Dergisi 19(1): 103¬110, 1992
26. Ailen AR. Reactive (AA) systemic amyloidosis. A cause of refractory nephrotic syndrome. BM.I 1996; 312: 1087-1089
27. Heeg JE, de Jong NF, Vriesendorp R, de Zeeuw D. Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril. Am J
Nephrol 1990; 10: 94-97
28. David J. Amyloidosis in juvenile chronic arthritis. Clin
Exp Rheumatol 1991; 9: 73-78
29. Berglund K, Keller C, Thysell H. Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic
disease. Ann Rheum Dis 1987; 46: 757-762
30. Ahlmen M, Ahlmen J, Svalander J, Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency.
Clin Rheumatology 1987; 6: 27-38
31. Falck HM, Törnroth T, Skrifvars B, Wegelius O. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Medica Scandinavica 1979;
205:651-656
146
Thank you for copying data from http://www.arastirmax.com